Company Valuation: Biosynex

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 151.6 289.9 141 85.85 18.51 11.17
Change - 91.16% -51.35% -39.13% -78.44% -39.63%
Enterprise Value (EV) 1 130.6 193.2 105.9 125.7 71.44 64.36
Change - 47.93% -45.16% 18.6% -43.14% -9.91%
P/E 5.44x 2.63x 9.08x -2.42x -0.43x -0.19x
PBR 2.29x 1.62x 0.87x 0.72x 0.23x 0.3x
PEG - 0x -0.1x 0x -0x 0x
Capitalization / Revenue 0.99x 0.76x 0.72x 0.92x 0.18x 0.12x
EV / Revenue 0.85x 0.5x 0.54x 1.35x 0.71x 0.68x
EV / EBITDA 2.84x 1.36x 2.28x -4.21x -3.22x -4.72x
EV / EBIT 2.86x 1.37x 2.72x -3.48x -2.59x -2.47x
EV / FCF 7.61x 2.62x -3.59x -2.83x -43.6x 4.54x
FCF Yield 13.1% 38.1% -27.9% -35.3% -2.29% 22%
Dividend per Share 2 0.2 2 - - - -
Rate of return 1.2% 7.6% - - - -
EPS 2 3.05 10.01 1.52 -3.45 -4.03 -3.159
Distribution rate 6.56% 20% - - - -
Net sales 1 153.9 382.5 196.6 92.98 101.2 95.19
EBITDA 1 46.02 141.8 46.49 -29.82 -22.16 -13.64
EBIT 1 45.73 140.7 38.88 -36.15 -27.53 -26.05
Net income 1 31.37 104 15.66 -36.95 -43.33 -58.22
Net Debt 1 -21.07 -96.72 -35.09 39.8 52.94 53.19
Reference price 2 16.6000 26.3200 13.8000 8.3500 1.7200 0.5960
Nbr of stocks (in thousands) 9,135 11,014 10,220 10,281 10,761 18,748
Announcement Date 21/04/21 25/04/22 28/04/23 30/04/24 30/04/25 07/05/26
1EUR in Million2EUR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 1.64Cr
34.64x4.1x15.4x2.48% 18TCr
22.15x3.76x13.44x2.77% 13TCr
27.38x4.87x16.69x1.13% 12TCr
31.38x3.03x12.19x2.27% 9.05TCr
18.59x0.22x13.83x0.68% 6.69TCr
43.91x3.87x13.16x1.94% 5.87TCr
45.82x11.51x32.28x-.--% 5.44TCr
27.89x6.9x17.49x1.44% 4.85TCr
46.12x3.46x12.8x0.5% 3.54TCr
Average 33.10x 4.63x 16.37x 1.47% 8TCr
Weighted average by Cap. 31.34x 4.35x 15.80x 1.77%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Biosynex

Historical PBR trend

Valuation ratios - PBR - Biosynex

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Biosynex

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Biosynex